Published on 2 Mar 2023 on Zacks via Yahoo Finance
Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates
Selecta Biosciences, Inc. (SELB) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this company would post earnings of $0.01 per share when it actually produced a loss of $0.01, delivering a surprise of -200%.